CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Metabolix,
Inc. (NASDAQ: MBLX), a bioscience company focused on developing
clean, sustainable solutions for plastics, chemicals and energy, today
announced that Lynne H. Brum has joined the company as vice president of
marketing and corporate communications and a member of the executive
management team. Ms. Brum is responsible for overseeing all aspects of
the company's marketing and corporate communications initiatives.
"Lynne brings a passion for both science and communications to her role
at Metabolix," said Richard P. Eno, president and CEO of Metabolix. "Her
communications expertise in the life sciences industry will be a
valuable asset to the company as we build awareness across our
bioplastic, chemical and crop platforms."
Ms. Brum has more than 20 years of experience leading communications
programs for technology-based life science companies. Prior to joining
Metabolix, she served as an executive vice president at Porter Novelli
Life Sciences — a subsidiary of global PR firm, Porter Novelli
International. Prior to that, Ms. Brum was responsible for corporate
communications, investor relations and brand management in her role as
vice president of strategic communications for Vertex Pharmaceuticals,
Inc. Ms. Brum was also a vice president at Feinstein Kean Healthcare and
was part of the communications team at Biogen, Inc. (now Biogen Idec).
Ms. Brum holds a bachelor's degree in biological sciences from Wellesley
College and a master's degree in business administration from Simmons
College's School of Management.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience
company focused on providing sustainable solutions for the world's needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is now
developing and commercializing Mirel™, a family of high performance
bioplastics which are biobased and biodegradable alternatives to many
petroleum-based plastics, through Telles, a joint venture of Metabolixand Archer Daniels Midland Company. Metabolix is also developing
biosourced industrial chemicals and a proprietary platform technology
for co-producing plastics, chemicals and energy, from crops such as
switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com.
(MBLX-G)
Media:
Schwartz MSL
Keith Giannini or Jen Barlow,
781-684-0770
metabolix@schwartzmsl.com
or
Investors:
ICR
James
Palczynski, 203-682-8229
james.palczynski@icrinc.com
Source: Metabolix, Inc.
News Provided by Acquire Media
